menu search

Arcutis to report second quarter financial results

WESTLAKE VILLAGE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc.  (Nasdaq: ARQT), an early commercial-stage bio...

July 24, 2023, 4:00 pm

Why shares of verrica pharmaceuticals are plummeting on monday

Verrica focuses on dermatology therapeutics. The company just received approval for its first marketed product....

July 24, 2023, 3:16 pm

Vertex shares have been heavily accumulated all year

Vertex pharmaceuticals, Inc. (VRTX) shares are up 25% in 2023. This uptrend is being powered by healthy...

July 24, 2023, 2:34 pm

Why is paxmedica (pxmd) stock up today?

Clinical-stage biopharmaceutical firm PaxMedica (NASDAQ: PXMD ) is experiencing a full range of emotion...

July 24, 2023, 2:17 pm

Kodiak sciences discontinues development of eye disorder therapeutic; shares plummet

Kodiak Sciences shares fell by more than 45% after the biopharmaceutical company announced that it was ...

July 24, 2023, 1:59 pm

Why shares of amylyx pharmaceuticals were up monday

Amylyx focuses on neurodegenerative diseases. After launching its first product in September, the company turned its first profitable quarter....

July 24, 2023, 12:17 pm

Following fda approval of ycanth™ for the treatment of molluscum contagiosum, verrica pharmaceuticals enters into non-binding term sheet for up to $125 million debt financing; company to host conferen

Term loan facility would provide for up to $125M in non-dilutive capital; $50M immediately available to Company following close of the transaction, wh...

July 24, 2023, 11:00 am

Annexon to report archer phase 2 trial results in geographic atrophy at asrs 2023

Company to hold investor conference call on Monday, July 31, 2023 at 1:30 p.m. PT / 4:30 p.m. ET BRISBANE, Calif., July 24, 2023 (GLOBE NEWSWIRE) — ...

July 24, 2023, 10:30 am

Gilead sciences shares decline after it discontinues blood cancer treatment trial

Gilead Sciences, Inc. (NASDAQ:GILD) started on the back foot on Monday after the biopharmaceutical com...

July 24, 2023, 10:27 am

Better big biotech buy: vertex vs. biogen

Vertex pharmaceuticals is heading for a big moment -- a regulatory decision on a potential new blockbus...

July 24, 2023, 10:09 am

Apellis pharmaceuticals to host conference call on july 31, 2023, to discuss second quarter 2023 financial results

WALTHAM, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- Apellis pharmaceuticals, Inc. (Nasdaq: APLS), a glob...

July 24, 2023, 9:00 am

Teva pharmaceuticals and alvotech expand biosimilars partnership

Teva pharmaceuticals Industries Ltd. TEVA, +0.47% and Alvotech ALVO, +0.51% announced Monday that they ...

July 24, 2023, 8:47 am

Lilly shares up on versanis deal amid weight-loss drug gold rush

Shares of Eli Lilly & Co. NYSE: LLY closed 2.80% higher for the week ended July 21, a week after Lilly said it would buy Versanis, a privately held cl...

July 24, 2023, 8:46 am

Catalyst pharmaceuticals to report second quarter 2023 financial results on august 9, 2023

The Company to Host a Conference Call and Webcast on August 10, 2023, at 8:30 AM ET The Company to Host a Conference Call and Webcast on August 10, 20...

July 24, 2023, 8:03 am

Cara therapeutics to announce second quarter 2023 financial results on august 7, 2023

STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage bio...

July 24, 2023, 7:00 am

Opthea to present at the 2023 ophthalmology innovation summit

MELBOURNE, Australia, July 24, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage bio...

July 24, 2023, 6:00 am

Buy spectrum pharmaceuticals for exposure to assertio holdings

Spectrum stockholders will receive contingent value rights, too, along with Assertio shares. The rewards are payable on achievement of 2024 and 2025 s...

July 24, 2023, 4:56 am

Roche enters partnership with alnylam for hypertension therapy

Swiss pharmaceutical group Roche said on Monday it had entered into a partnership with U.S. bio...

July 24, 2023, 1:18 am

Shareholder investigation: halper sadeh llc investigates dffn, trtn, cnxc

NEW YORK, July 23, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...

July 23, 2023, 2:50 pm

Diving into day one biopharmaceuticals

Shares of precision oncology concern Day One Biopharmaceuticals, Inc. are down over 50% from their 2023...

July 23, 2023, 4:43 am


Search within

Pages Search Results: